Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New pharmacon allows testicular tumors to shrink

28.12.2016

A new active pharmaceutical ingredient may help against severe forms of testicular cancer, which only respond inadequately to other therapies. In mice, the substance kills degenerated cells and allows testicular tumors to shrink. Researchers at the University of Bonn were able to demonstrate this in a recent study. However, first clinical trials are still pending. The work has now been published in the “Journal of Cellular and Molecular Medicine”.

Testicular cancer is the most common malignant tumor disease in men between 20 and 40 years of age. It can usually be treated well. In some cases, however, the cancer hardly responds or does not respond at all to treatment.


Prof. Hubert Schorle (left), Dr. Daniel Nettersheim (center) and PhD student Sina Jostes (right) investigate changes in gene expression following JQ1 treatment in testicular cancer cells.

Photo: Simon Schneider/Institute for Pathology/UKB

A substance that was originally destined to be an innovative contraceptive is offering new hope in these cases. An experimental drug with the cryptic name JQ1 blocks sperm maturation and was discussed to be a male contraceptive. Instead, it may be suitable for cancer therapy.

JQ1 belongs to a new class of drugs with far-reaching abilities: its members fundamentally influence which genes in the cell are active and which are not. The hereditary material DNA is similar to an extremely long strip of Morse code, on which the assembly instructions for the cellular molecules are found. To fit into the cell nuclei, this strip of Morse code is wrapped around small protein balls at regular intervals – the histones. Histones and DNA together resemble a string of pearls.

However, the histones do not only play a structural role. They also feature chemical tags – called methyl or acetyl groups. These tags signal to the synthesis machinery in the cell whether the strip of Morse code should be read at this point or not. “JQ1 inhibits those proteins that read these histone marks and thus changes the gene activity in the cell,” explains Prof. Hubert Schorle from the Institute for Pathology at the University of Bonn.

The cancer cells react very sensitive to these changes: they activate a suicide program, called apoptosis. “In a testicular cancer mouse model, the tumors began to shrink after administering JQ1,” explains the lead author of the study, Sina Jostes. “In contrast, healthy skin cells seem to tolerate JQ1 very well.”

Especially effective in combination

Besides JQ1, other drugs that alter the marks of the histones are also known. One of these is romidepsin. The laboratory in Bonn was recently able to show that romidepsin is also very effective at fighting testicular cancer cells. Unlike JQ1, romidepsin is already approved for the treatment of patients with certain types of cancer.

“In our study, we treated mice with both JQ1 and romidepsin,” explains Dr. Daniel Nettersheim, who helped in planning and performing the studies. “This way, we achieved a similar effect alike JQ1 or romidepsin treatment alone, but we could reduce the quantities of both substances. Such a combination therapy to treat testicular tumors may be much better tolerated. Chemotherapy-resistant patients could also benefit from this.” However, clinical studies are now needed to move the treatment towards the clinics.

Besides scientists from the University of Bonn, the studies also involved researchers from the University of St. Gallen (Switzerland) and Harvard Medical School (USA).

Publications:

Sina Jostes, Daniel Nettersheim, Martin Fellermeyer, Simon Schneider, Francois Hafezi, Friedemann Honecker, Valerie Schumacher, Matthias Geyer, Glen Kristiansen and Hubert Schorle: The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo; Journal of Cellular and Molecular Medicine; DOI: 10.1111/jcmm.13059

Daniel Nettersheim, Sina Jostes, Martin Fabry, Friedemann Honecker, Valerie Schumacher, Jutta Kirfel, Glen Kristiansen and Hubert Schorle: A signaling cascade including ARID1A, GADD45B and DUSP1 induces apoptosis and affects the cell cycle of germ cell cancers after romidepsin treatment; Oncotarget; DOI: 10.18632/oncotarget.11647

Media contact:

Prof. Hubert Schorle
Institute of Pathology
University of Bonn
Telephone: +49 (0)228/28716342
E-mail: hubert.schorle@ukb.uni-bonn.de

Dr. Andreas Archut | idw - Informationsdienst Wissenschaft

More articles from Health and Medicine:

nachricht Penn study identifies new malaria parasites in wild bonobos
21.11.2017 | University of Pennsylvania School of Medicine

nachricht NIST scientists discover how to switch liver cancer cell growth from 2-D to 3-D structures
17.11.2017 | National Institute of Standards and Technology (NIST)

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Previous evidence of water on mars now identified as grainflows

21.11.2017 | Physics and Astronomy

NASA's James Webb Space Telescope completes final cryogenic testing

21.11.2017 | Physics and Astronomy

New catalyst controls activation of a carbon-hydrogen bond

21.11.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>